Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

…, JA Nelson, M Chaubal, J Werling, J Kipp… - Blood, 2006 - ashpublications.org
Complex dosing regimens, costs, side effects, biodistribution limitations, and variable drug
pharmacokinetic patterns have affected the long-term efficacy of antiretroviral medicines. To …

Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects

…, P Papadopoulos, B Rabinow, J Kipp… - Advanced drug delivery …, 2008 - Elsevier
There has been growing interest in nanoparticles as an approach to formulate poorly
soluble drugs. Besides enhanced dissolution rates, and thereby, improved bioavailability, …

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS

…, CJ Destache, M Chaubal, J Werling, J Kipp… - The Journal of …, 2009 - journals.aai.org
Antiretroviral therapy (ART) shows variable blood-brain barrier penetration. This may affect
the development of neurological complications of HIV infection. In attempts to attenuate viral …

Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat

B Rabinow, J Kipp, P Papadopoulos, J Wong… - International journal of …, 2007 - Elsevier
The goal of this research was to evaluate an intravenous itraconazole nanosuspension
dosage form, relative to a solution formulation, in the rat. Itraconazole was formulated as a …

[HTML][HTML] Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived …

…, L Shlyakhtenko, Y Zhou, M Chaubal, J Werling, J Kipp… - Virology, 2007 - Elsevier
The effectiveness of anti-retroviral therapies (ART) depends on its ultimate ability to clear
reservoirs of continuous human immunodeficiency virus (HIV) infection. We reasoned that a …

Excipient selection and criteria for injectable dosage forms

MV Chaubal, J Kipp, B Rabinow - Excipient development for …, 2006 - taylorfrancis.com
Development of injectable formulations typically requires specific considerations on the type
and quality of excipients used. The criteria for excipient selection depend on a number of …

Mechanism of 2-hydropropyl-beta-cyclodextrin in the stabilization of frozen formulations

J Wong, JE Kipp, RL Miller, LM Nair, GJ Ray - European Journal of …, 2014 - Elsevier
Freezing of commonly used parenteral products to increase pharmaceutical stability for cost-saving
purposes is a common practice in patient care. However, frozen meropenem, a …

Nonisothermal stability assessment of stable pharmaceuticals: testing of a clindamycin phosphate formulation

JE Kipp, JJ Hlavaty - Pharmaceutical research, 1991 - Springer
The stability of an antibiotic formulation (clindamycin phosphate in dextrose), which is stable
at room temperature, was assessed by nonisothermal kinetic analysis at elevated …

Solubilizing systems for parenteral formulation development—small molecules

JE KIPP - Solvent systems and their selection in pharmaceutics …, 2007 - Springer
“Parenteral” is defined 1 as “situated or occurring outside the intestine, and especially
introduced otherwise than by way of the intestines”—pertaining to essentially any administration …

[BOOK][B] Stress-relief fracture control of ground-water movement in the Appalachian Plateaus

JA Kipp, JS Dinger - 1991 - kgs.uky.edu
The Kentucky Geological Survey has been conducting studies in the Eastern Kentucky Coal
Field since 1980 to determine the various hydrogeologic conditions that exist in the region. …